Nitrous Oxide and Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study

This study has been completed.
Sponsor:
Collaborator:
The Cleveland Clinic
Information provided by:
Outcomes Research Consortium
ClinicalTrials.gov Identifier:
NCT00781352
First received: October 27, 2008
Last updated: October 28, 2008
Last verified: October 2008

October 27, 2008
October 28, 2008
November 1998
November 2003   (final data collection date for primary outcome measure)
To determine if the risk of colorectal cancer recurrence was similar in patients who were randomly assigned to 65% nitrous oxide or nitrogen during colorectal surgery. [ Time Frame: 270 days post surrgery ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00781352 on ClinicalTrials.gov Archive Site
 
 
 
 
 
Nitrous Oxide and Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study
Nitrous Oxide Does Not Increase the Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study

This study was developed to test the hypothesis that the risk of colorectal cancer recurrence was similar in patients who were randomly assigned to 65% nitrous oxide or nitrogen during colorectal surgery.

We conducted a 4- to 8-year follow-up of 204 patients with colorectal cancer who were randomly assigned to 65% nitrous oxide (n=97) or nitrogen (n=107), balanced with isoflurane and remifentanil. The primary outcome was the time to cancer recurrence. Our primary analysis was a multivariable Cox-proportional-hazards regression model that included relevant baseline variables. In addition to treatment group, the model considered patient age, tumor grade, dissemination, adjacent organ invasion, vessel invasion, and the number of nodes involved. The study had 80% power to detect a 56% or greater reduction in recurrence rates (i.e., hazard ratio of 0.44 or less) at the 0.05 significance level.

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Prevention
Colorectal Cancer
  • Drug: nitrous oxide
    65% nitrous oxide administered during surgery
  • Drug: nitrogen
    Nitrogen administration during surgery
  • Active Comparator: group 1
    Colorectal surgery with 65% nitrous oxide administration
    Intervention: Drug: nitrous oxide
  • Active Comparator: group 2
    Colorectal surgery with nitrogen administration
    Intervention: Drug: nitrogen
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
408
March 2007
November 2003   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects age 18-18
  • ASA status 1-3
  • Informed consent

Exclusion Criteria:

  • Acute bowel obstruction
  • Minor colon surgery
Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
Austria
 
NCT00781352
efno1008
No
Edith Fleischmann, Medical University of Vienna
Outcomes Research Consortium
The Cleveland Clinic
Principal Investigator: Edith Fleischmann, M.D. Medical University of Vienna
Study Director: Daniel I Sessler, M.D. The Cleveland Clinic
Outcomes Research Consortium
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP